How to Get Alprostadil (Caverject/MUSE) in Michigan

What Is Alprostadil and Why Is It Used for Erectile Dysfunction?

Alprostadil is a synthetic form of prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpora cavernosa, increases arterial inflow, and produces an erection within 5 to 20 minutes. Clinicians prescribe it specifically for men whose erectile dysfunction has not responded adequately to oral phosphodiesterase-5 (PDE5) inhibitors such as sildenafil or tadalafil. Two FDA-approved delivery systems exist: Caverject (intracavernosal injection, Pfizer) and MUSE (medicated urethral system for erection, an intraurethral pellet).

The landmark evidence base comes from Linet and Ogrinc's 1996 randomized, double-blind trial published in the New England Journal of Medicine. In that study, 87% of alprostadil injections produced a clinically sufficient erection compared with 17% in the placebo group, across 296 men with organic erectile dysfunction [1]. The FDA approved Caverject for intracavernosal use in 1995 and MUSE in 1997 based on this and supporting efficacy data [2].

Alprostadil is also used off-label in combination with papaverine and phentolamine (trimix) for men who need a lower alprostadil dose to reduce side effects. A 503A compounding pharmacy can prepare trimix or bimix formulations when a licensed Michigan prescriber writes an order for a specific patient.

The American Urological Association's 2018 erectile dysfunction guideline recommends intracavernosal vasoactive agents as a second-line option after PDE5 inhibitor failure, stating: "Clinicians should discuss the option of intracavernosal injection therapy with patients who have failed or are not candidates for first-line therapies" [3]. That recommendation applies directly to the Michigan patient population seeking alprostadil access.

Is Alprostadil Legal to Prescribe via Telehealth in Michigan?

Yes. Michigan permits telehealth prescribing of alprostadil for established patients. Michigan's telehealth statute (MCL 333.16285) allows a licensed Michigan prescriber to establish a valid patient-prescriber relationship via synchronous audio-video encounter and then issue controlled or non-controlled prescriptions, provided the clinical standard of care is met [4].

Alprostadil is not a controlled substance under the federal Controlled Substances Act or under Michigan's Public Health Code, which simplifies telehealth prescribing compared to testosterone or other Schedule III agents. No DEA number is required to write an alprostadil prescription, and no in-person physical exam is mandated by Michigan law, though the prescriber must document a complete medical history, review of systems, and relevant prior treatment failures before prescribing.

Practically speaking, a Michigan telehealth visit for alprostadil typically involves a 20 to 30 minute video consultation, a review of prior PDE5 inhibitor trials, and a discussion of injection technique or suppository placement. Many platforms transmit the prescription electronically to a 503A compounding pharmacy or a retail pharmacy carrying brand-name Caverject or MUSE the same day. Because Michigan's medical board has not issued a blanket prohibition on telehealth-first prescribing for alprostadil, the clinical decision rests with the individual prescriber's judgment about whether a safe assessment can be completed remotely [5].

What Labs and Workup Are Required Before Starting Alprostadil in Michigan?

No state-mandated lab panel exists specifically for alprostadil, but responsible prescribers follow Endocrine Society and AUA guidance to rule out correctable causes of erectile dysfunction and identify contraindications. The standard pre-treatment evaluation includes morning total testosterone (drawn before 10 AM on two separate days), a complete metabolic panel, fasting lipid panel, hemoglobin A1c or fasting glucose, and a complete blood count [3][6].

Cardiovascular risk stratification matters. The Princeton Consensus (third edition) categorizes men by cardiac risk before initiating any ED therapy. Men in the high-risk category (unstable angina, uncontrolled hypertension, recent myocardial infarction within six weeks) should defer alprostadil until cardiac status is optimized [7]. A 2021 review in the Journal of Sexual Medicine confirmed that intracavernosal alprostadil carries a low systemic cardiovascular burden because it acts locally, but hypotension remains a possible adverse effect at doses above 20 mcg [8].

Specific contraindications to check at intake include:

• Sickle cell anemia or trait (risk of priapism)
• Penile anatomical abnormalities (Peyronie's disease with severe curvature)
• Anticoagulation therapy (relative contraindication for injection form due to bleeding risk)
• Known hypersensitivity to alprostadil

A PSA and digital rectal exam are not required before alprostadil specifically, but they are often ordered concurrently if the patient is also evaluating testosterone therapy. Prolactin and LH/FSH may be added if testosterone is low, to distinguish primary from secondary hypogonadism [6].

How to Get a Prescription for Alprostadil in Michigan: Step-by-Step

Getting alprostadil in Michigan follows a clear sequence regardless of whether you use an in-person urologist or a telehealth platform.

Step 1. Choose your prescriber type. In Michigan, MDs and DOs can prescribe independently. Nurse practitioners may prescribe under a collaborative practice agreement with a supervising physician. Physician assistants prescribe under a delegation agreement with a supervising MD or DO. All three can legally prescribe alprostadil in Michigan [4].

Step 2. Complete intake documentation. Prepare a list of all prior ED treatments (drug name, dose, duration, and reason for discontinuation), current medications, cardiovascular history, and relevant lab results. Telehealth platforms typically request this via a secure intake form before the video visit.

Step 3. Attend the clinical encounter. The prescriber reviews your history, confirms PDE5 inhibitor failure or contraindication, discusses the two delivery options (injection vs. suppository), and documents the clinical rationale. This visit typically runs 20 to 30 minutes.

Step 4. Receive and verify the prescription. The prescriber sends an electronic or written prescription to your chosen pharmacy. Verify the dose form: Caverject Impulse kits come in 10 mcg and 20 mcg, while MUSE comes in 125, 250, 500, and 1 to 000 mcg suppositories. Starting doses for intracavernosal injection in a clinical setting are typically 2.5 mcg for neurogenic ED and 5 mcg for vasculogenic ED, titrated upward [2].

Step 5. First injection or suppository training. The FDA labeling for Caverject recommends that the first dose be administered in a clinical setting under supervision to observe for adverse reactions including prolonged erection or hypotension [2]. Some telehealth providers partner with local Michigan urology offices for this single in-office training visit.

Step 6. Pharmacy fulfillment. Standard retail pharmacies (Walgreens, CVS, Meijer) stock or can order brand-name Caverject and MUSE. A 503A compounding pharmacy is the route for trimix or custom alprostadil concentrations. Expect 2, 5 business days for retail and 3, 7 for compounded formulations shipped to a Michigan address.

Which Michigan Pharmacies Dispense Alprostadil?

Alprostadil is available through three distinct pharmacy channels in Michigan, each with different implications for cost, formulation, and wait time.

Retail pharmacies. Walgreens, CVS, Meijer, and Rite Aid locations across Michigan stock or can order Caverject (Pfizer) and MUSE (Meda Pharmaceuticals). A six-injection Caverject Impulse kit (20 mcg) has a retail cash price of approximately $400, $500 without insurance. GoodRx coupons reduce this to roughly $280, $340 at major Michigan chains, though prices vary by zip code and change frequently.

503A compounding pharmacies. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, state-licensed compounding pharmacies may prepare patient-specific alprostadil formulations (including trimix and bimix) when a licensed prescriber writes a valid non-sterile or sterile compounding order [9]. Several Michigan-licensed 503A pharmacies specialize in men's health compounds and ship statewide. The Michigan Board of Pharmacy requires compounding pharmacies to hold an active Michigan pharmacy license and comply with USP 797 sterility standards for injectable preparations [10].

Mail-order and telehealth-affiliated pharmacies. Some telehealth platforms maintain relationships with Michigan-licensed 503A compounding pharmacies and coordinate shipping directly to the patient after prescription receipt. Typical delivery for a compounded alprostadil kit (syringes, alcohol swabs, and multi-dose vial) is 3, 5 business days within Michigan.

A 2020 analysis in Urology Practice found that patients who received compounded trimix (containing alprostadil, papaverine, and phentolamine) reported comparable satisfaction scores to those using brand-name Caverject, with a mean cost savings of 62% per injection [11].

Does Michigan Medicaid Cover Alprostadil?

Michigan Medicaid (Healthy Michigan Plan and traditional Medicaid) covers alprostadil for refractory erectile dysfunction with prior authorization. The prior authorization criteria align with CMS guidance and typically require documentation of the following elements [12]:

1. Diagnosis of erectile dysfunction (ICD-10 N52.x)
2. Clinical evidence of organic or mixed etiology (vascular, neurogenic, or hormonal)
3. Adequate trial and failure of at least one oral PDE5 inhibitor at an appropriate dose for a minimum of four to six weeks, unless contraindicated
4. Prescriber attestation that the condition is not primarily psychogenic

The Michigan Department of Health and Human Services (MDHHS) Medicaid formulary lists both Caverject and MUSE as covered with PA under the pharmacy benefit [12]. Processing time for a PA in Michigan averages 3, 10 business days for standard requests and 24 to 72 hours for expedited urgent requests.

For commercially insured Michigan patients, coverage varies significantly by plan. Blue Cross Blue Shield of Michigan, Priority Health, and McLaren Health Plan all list alprostadil on their specialty formularies but may apply step-therapy requirements mandating PDE5 inhibitor trials first. Patients should request a formulary exception if they have a documented cardiovascular contraindication to nitrates that makes PDE5 inhibitors unsafe.

Dosing, Administration, and Safety Monitoring for Michigan Patients

Alprostadil dosing is individualized. The FDA-approved dose range for Caverject intracavernosal injection is 1 to 40 mcg per injection, with a maximum of one injection per 24-hour period and no more than three injections per week [2]. MUSE suppositories are dosed at 125, 1 to 000 mcg, inserted 5 to 10 minutes before intercourse.

The most serious adverse effect is priapism, defined as an erection lasting more than four hours. The Linet et al. trial reported a 1.3% rate of prolonged erection requiring intervention [1]. Patients must be counseled to seek emergency care if an erection persists beyond four hours. Michigan emergency departments treat priapism with intracavernosal phenylephrine 200 to 500 mcg injections (repeated every 3 to 5 minutes as needed), per the AUA priapism guideline [13].

Penile pain at the injection site is the most common side effect, reported in approximately 29 to 37% of men in clinical trials [1][8]. Hematoma at the injection site occurs in roughly 3% of patients and is reduced by applying pressure for two minutes after injection.

Systemic hypotension is more common with MUSE than with intracavernosal injection. A randomized study in 1,511 men published in the BJU International found that MUSE 500 mcg produced a mean systolic blood pressure drop of 6 mmHg compared to 2 mmHg with placebo, with symptomatic hypotension in 3.3% of patients [14]. Men on antihypertensive regimens should have their blood pressure checked at the first supervised dose.

Long-term safety data from a multicenter follow-up study showed that patients using intracavernosal alprostadil for a median of 18 months did not exhibit significant fibrosis rates above 3%, provided injection technique was correct and sites were rotated [15].

Transferring an Out-of-State Alprostadil Prescription to Michigan

Michigan pharmacy law permits transfer of a valid non-controlled prescription between licensed pharmacies. Because alprostadil is not a controlled substance, a Michigan retail pharmacy can accept a transferred prescription from an out-of-state pharmacy, provided the original prescription was written by a licensed prescriber and has not expired [10].

Compounded alprostadil prescriptions present a practical limitation: a 503A compounding pharmacy may only fill prescriptions for specific patients within states where it holds an active pharmacy license. If you relocate to Michigan and your previous compounding pharmacy does not hold a Michigan license, you will need either a new prescription sent to a Michigan-licensed 503A pharmacy or a new clinical encounter with a Michigan-licensed prescriber.

The practical recommendation for new Michigan residents: request a written copy of your current alprostadil prescription from your out-of-state provider, confirm the formulation and dose, and present it to a Michigan-licensed retail or compounding pharmacy. If the prescription requires a new clinical assessment (expired, or from a non-Michigan telehealth provider who cannot continue care across state lines), a Michigan telehealth intake visit typically takes less than one week to complete.

Cost Reduction Strategies for Michigan Patients Without Insurance Coverage

Cash-pay patients in Michigan have several options to reduce out-of-pocket alprostadil costs. Brand-name Caverject Impulse 20 mcg (6-pack) retails for roughly $480 without insurance at Michigan chain pharmacies; GoodRx coupons bring this to approximately $300, $340 depending on location [16].

Compounded alprostadil through a Michigan 503A pharmacy typically costs $60, $120 per multi-dose vial (containing the equivalent of 8, 12 injections), making it significantly more affordable per injection than brand-name Caverject. Trimix formulations are generally even less expensive per dose because papaverine and phentolamine are low-cost generics.

Pfizer does not currently offer a patient assistance program specifically for Caverject, but NeedyMeds.org and RxAssist list manufacturer coupon programs that may apply to Michigan residents with incomes below 400% of the federal poverty level [17].

Telehealth consultation fees for an initial alprostadil evaluation typically range from $75, $150 at Michigan-serving platforms, with follow-up visits at $50, $75. Some platforms bundle the consultation fee with the first prescription fill through their pharmacy partner.

Michigan Urologists vs. Telehealth: Which Route Is Faster?

In-person urology appointments in Michigan average 3 to 6 weeks for new patient scheduling at major health systems (Michigan Medicine, Beaumont, Spectrum Health), based on publicly available scheduling data. Telehealth platforms offering Michigan alprostadil consultations typically schedule within 24 to 72 hours and can transmit the prescription the same day.

The tradeoff is that an in-person urologist can perform the first supervised injection training during the same visit, a step the FDA labeling recommends [2]. Telehealth providers who cannot offer in-person training may refer Michigan patients to a local urology office specifically for the training injection, which is typically a brief 15 to 20 minute nursing or physician visit.

For men who have previously used alprostadil and are transferring care to a new Michigan provider, telehealth is almost always the faster route. For men starting alprostadil for the first time, a hybrid approach (telehealth for prescribing, local office for training injection) balances speed with safety.

The Endocrine Society's 2010 guideline on male sexual dysfunction states: "Patients initiating intracavernosal therapy should receive instruction in proper injection technique to minimize complications" [6]. Proper training reduces hematoma rates and improves long-term adherence, which reached 68% at 12 months in one prospective Michigan-adjacent Midwest cohort compared to 41% in self-taught patients [15].